Thiti Swangsilpa
Papers
2
Total Citations
45
H-Index
2
About
Dr. Thiti Swangsilpa is a leading radiation oncologist specializing in stereotactic radiosurgery (SRS) and hypofractionated stereotactic radiotherapy (HSRT) for intracranial tumors. Her research focuses on optimizing the precision of CyberKnife robotic radiosurgery to treat complex, radiation-sensitive lesions near critical structures. In her highly cited 2015 study (32 citations), Dr. Swangsilpa demonstrated the clinical efficacy of hypofractionated stereotactic radiotherapy for perioptic pituitary adenomas, establishing a safer alternative to single-fraction radiosurgery by respecting the optic pathway's radiation tolerance. Her subsequent 2021 work (13 citations) provided long-term outcome data for vestibular schwannoma patients treated with frameless CyberKnife SRS and HSRT, confirming durable tumor control and favorable toxicity profiles. These contributions have advanced the evidence base for fractionated stereotactic approaches, offering patients with benign skull base tumors a non-invasive treatment option that minimizes damage to adjacent cranial nerves. Dr. Swangsilpa’s research underscores the critical balance between tumor control and organ-at-risk preservation, making her a key voice in modern stereotactic radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2